iota Biosciences
http://iota.bio
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From iota Biosciences
Beyond The Pandemic, An Interview With Astellas’ Percival Barretto-Ko
Astellas Pharma US accounts for roughly one-third of the parent company’s annual revenues with a growing focus on immuno-oncology. The unit’s president discusses lessons from the pandemic, racial disparities in health care and business development.
Astellas Pays $300m+ For iota In ‘Pharma-Plus’ Push
Japanese major builds presence in novel device technology beyond its conventional therapeutics as looks towards a more holistic future of care.
Company Information
- Industry
- Digital Health
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
Diagnostic Imaging Equipment & Supplies
- Ultrasound
-
In Vitro Diagnostics
- Biosensors